Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $29.71 USD
Change Today +1.16 / 4.06%
Volume 136.1K
XLRN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. Knopf Ph.D.

Founder, Chief Executive Officer, President and Director,Acceleron Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 2 different industries.

See Board Relationships
63$738,500
As of Fiscal Year 2014

Background*

Dr. John L. Knopf, Ph.D., Co-founded Acceleron Pharma Inc. in 2003 and has been its Chief Executive Officer since September 18, 2007. Dr. Knopf serves as an Executive Vice President of Corporate Development and President at Acceleron Pharma, Inc. and served as its Interim President. He serves as Director of Product Management of NetMotion Wireless, Inc. He served as Director of Marketing for NetMotion Wireless, Inc. since June 2006. He served as Co-Founder of Jasbir ...

Read Full Background

Corporate Headquarters*

128 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-649-9200
Fax: 617-649-9988

Board Members Memberships*

2007-Present
Founder, Chief Executive Officer, President and Director

Education*

PhD
University at Buffalo
BS
State University of New York at Stony Brook

Other Affiliations*

Annual Compensation*

Salary$460,000
Total Annual Compensation$460,000

Stock Options*

All Other Compensation$2,500
Exercisable Options692,344
Unexercisable Options242,656
Total Number of Options935,000

Total Compensation*

Total Annual Cash Compensation$738,500
Total Short Term Compensation$460,000
Other Long Term Compensation$2,500
Total Calculated Compensation$738,500
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XLRN:US $29.71 USD +1.16

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCELERON PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.